JPS54126737A - Antithrombotic agent - Google Patents

Antithrombotic agent

Info

Publication number
JPS54126737A
JPS54126737A JP3061878A JP3061878A JPS54126737A JP S54126737 A JPS54126737 A JP S54126737A JP 3061878 A JP3061878 A JP 3061878A JP 3061878 A JP3061878 A JP 3061878A JP S54126737 A JPS54126737 A JP S54126737A
Authority
JP
Japan
Prior art keywords
antithrombotic agent
oral administration
effective component
containing pantethine
pantethine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3061878A
Other languages
Japanese (ja)
Other versions
JPS6213325B2 (en
Inventor
Tomomichi Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP3061878A priority Critical patent/JPS54126737A/en
Publication of JPS54126737A publication Critical patent/JPS54126737A/en
Publication of JPS6213325B2 publication Critical patent/JPS6213325B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: An antithrombotic agent which effectively suppresses the coagulation of thrombocyte, containing pantethine, which is a precursor of coenzyme A, as an effective component.
CONSTITUTION: An antithrombotic agent for oral administration, injection, etc., containing pantethine as an effective component. For oral administration, it is preferably diluted with crystalline cellulose, fumed silica, starch, etc. Dose: 600W 1000 mg/day for oral administration.
COPYRIGHT: (C)1979,JPO&Japio
JP3061878A 1978-03-17 1978-03-17 Antithrombotic agent Granted JPS54126737A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3061878A JPS54126737A (en) 1978-03-17 1978-03-17 Antithrombotic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3061878A JPS54126737A (en) 1978-03-17 1978-03-17 Antithrombotic agent

Publications (2)

Publication Number Publication Date
JPS54126737A true JPS54126737A (en) 1979-10-02
JPS6213325B2 JPS6213325B2 (en) 1987-03-25

Family

ID=12308846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3061878A Granted JPS54126737A (en) 1978-03-17 1978-03-17 Antithrombotic agent

Country Status (1)

Country Link
JP (1) JPS54126737A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028523A1 (en) * 2002-09-30 2004-04-08 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
JP2006265237A (en) * 2005-02-28 2006-10-05 Daiichi Sankyo Healthcare Co Ltd Composition for increasing glutathione peroxidase activity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028523A1 (en) * 2002-09-30 2004-04-08 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
CN100362987C (en) * 2002-09-30 2008-01-23 第一制药株式会社 Particulate product comprising pantethine
US7709028B2 (en) 2002-09-30 2010-05-04 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
JP2006265237A (en) * 2005-02-28 2006-10-05 Daiichi Sankyo Healthcare Co Ltd Composition for increasing glutathione peroxidase activity

Also Published As

Publication number Publication date
JPS6213325B2 (en) 1987-03-25

Similar Documents

Publication Publication Date Title
JPS5228947A (en) Oral remedy for hyperlipemia
JPS5332124A (en) Carcinostatic agent
JPS51144734A (en) A remedy for hepatic failure
JPS52108028A (en) Remedies for dysacousis
JPS54126737A (en) Antithrombotic agent
JPS5296731A (en) Prophylactics and remedies of cyanomycosis
NO153951C (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING 8-METOXY-FURO- (3 [, 2 [: 6,7) -CUMARIN.
JPS51144735A (en) A remedy for hepatic failure
JPS545046A (en) Cephalosporin preparation for oral administration
JPS5420127A (en) Solid nifedipine preparaton
JPS54126738A (en) Remedy for heart diseases
JPS51144732A (en) A remedy for hepatic failure
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
JPS5746915A (en) Antiallergic agent
JPS5498339A (en) Carcinostatic agent
JPS5277110A (en) Detergent composition
JPS5742620A (en) Novel antiulcer agent
JPS5381613A (en) Remedies for enteral infection diseases
JPS5346937A (en) Preparation of n-p-aminobenzoyl-n,-p-aminourea
JPS53148536A (en) Carcinostatic agent containing trans-4-aminomethylcyclohexane-1-carboxylic acid derivative
JPS52118453A (en) Indene derivatives
JPS5299221A (en) Medicines for alveolar ectasia
JPS5412385A (en) Carbostyril derivative
IE780530L (en) Anti-histamine salts and compositions